Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Curcumin for Radiation Dermatitis
NCT01246973Phase 3Completed
- Sponsor
- University of Rochester
- Start
- Feb 2011
- Primary completion
- Nov 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 3 trial of curcumin in radiation dermatitis, sponsored by University of Rochester. Started Feb 2011; status: completed.
02
Drugs
curcumin
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT01246973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246973.